ICON plc cash flow statement ICLR

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, ICON plc generated $1.0 billion of cash from operations, down 19.5% from the year before. It spent $174.2 million on capital expenditures. That left free cash flow of $862.0 million. The company returned $750.0 million in share buybacks to shareholders.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2014
Dec 31, 2014
Operating
Depreciation and amortization
383
-21.6%
488
-16.6%
586
+2.9%
570
+80.8%
315
+376.3%
66
+7.4%
62
-6.6%
66
+7.5%
61
+2.9%
53
+13.0%
Stock-based compensation
102
+122.5%
46
-17.6%
56
-21.1%
71
-47.3%
134
+409.5%
26
-2.0%
27
-15.1%
32
+3.3%
31
-24.2%
23
+59.9%
Operating cash flow
1,036
-19.5%
1,287
+10.8%
1,161
+106.1%
563
-32.1%
829
+46.0%
568
+37.7%
413
+53.6%
269
-29.9%
383
170
-23.2%
Investing
Capital expenditures
174
+3.7%
168
+19.5%
141
-1.0%
142
+51.6%
94
+129.3%
41
+5.0%
39
-19.5%
48
+8.2%
45
+5.0%
33
+11.2%
Investing cash flow
-188
+29.7%
-267
-17.7%
-227
-55.4%
-146
+97.6%
-6,024
-12834.2%
-47
+71.3%
-162
-334.4%
-37
+79.0%
-178
-112
+39.1%
Financing
Stock buybacks
750
+50.0%
500
0
-100.0%
100
0
-100.0%
175
+19.1%
147
+13.9%
129
-3.1%
133
+21.0%
140
+797.3%
Financing cash flow
-771
+7.9%
-837
+0.8%
-844
+2.3%
-864
-116.9%
5,115
+2555.1%
-208
-66.1%
-125
-11.0%
-113
+5.2%
-119
-116
-504.2%
Change in cash
Effect of exchange rate
31
+241.4%
-22
-2106.2%
-1
+94.0%
-17
-116.4%
-8
-212.5%
7
+1156.9%
-1
—
—
—
Net change in cash
109
-32.5%
161
+79.9%
89
+119.3%
-463
-426.1%
-88
-127.5%
320
+157.1%
124
—
—
—
Free cash flow
862
-22.9%
1,119
+9.6%
1,020
+142.3%
421
-42.7%
735
+39.5%
527
+41.1%
374
+69.6%
220
-34.9%
338
137
-28.5%
Per share
Free cash flow per share
10.92
-19.0%
13.47
+9.2%
12.34
+141.5%
5.11
-52.7%
10.80
+9.2%
9.89
+43.9%
6.88
+71.1%
4.02
-34.8%
6.17
2.17
-29.5%
Shareholder returns
Returned to shareholders
750
500
0
100
0
175
147
129
133
140
Share of free cash flow
87.01%
44.70%
0.00%
23.74%
0.00%
33.20%
39.33%
58.55%
39.34%
102.09%
Ratios
Free cash flow margin
10.45%
13.66%
12.67%
5.44%
13.42%
18.85%
13.31%
8.48%
19.24%
9.12%
Capital expenditures to revenue
2.11%
2.05%
1.75%
1.84%
1.71%
1.46%
1.39%
1.86%
2.54%
2.18%
Stock-based compensation to revenue
1.24%
0.56%
0.69%
0.91%
2.44%
0.94%
0.96%
1.22%
1.74%
1.51%
Cash conversion
4.52x
1.74x
2.09x
1.11x
5.41x
1.71x
1.10x
0.83x
1.36x
0.99x
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
ICLR (Nasdaq)
Headquarters
Dublin 18, Ireland
SEC filer status
Large accelerated filer
SEC CIK
1060955
Former names
ICON PLC /ADR/ (until Feb 7, 2013)

Other Services-Commercial Physical & Biological Research companies

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.